Trial intelligence / Profile preview

Tianshu capsule for anxiety headache

ChiCTR-IPR-16008798Phase 4Recruiting

Sponsor
Nanjing Drum-Tower Hospital
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Tianshu in anxiety disorder, migraine and tension-type headache (TTH) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Hamilton Anxiety Scale (HAMA), Self-Rating Anxiety Scale (SAS) and 2 more. Started Jul 2016; status: recruiting.

02

Drugs

Tianshu
03

Conditions

anxiety disordermigrainetension-type headache (TTH)

Beyond the preview

Go deeper on ChiCTR-IPR-16008798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16008798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call